English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  TGGE screening of the entire FBN1 coding sequence in 126 individuals with marfan syndrome and related fibrillinopathies

Katzke, S., Booms, P., Tiecke, F., Palz, M., Pletschacher, A., Türkmen, S., et al. (2002). TGGE screening of the entire FBN1 coding sequence in 126 individuals with marfan syndrome and related fibrillinopathies. Human Mutation, 20(3), 197-208.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Katzke, Stefanie, Author
Booms, Patrick, Author
Tiecke, Frank, Author
Palz, Monika, Author
Pletschacher, Angelika, Author
Türkmen, Seval1, Author           
Neumann, Luitgard M., Author
Pregla, Reinhard, Author
Leitner, Christa, Author
Schramm, Cornelia, Author
Lorenz, Peter, Author
Hagemeier, Christian, Author
Fuchs, Josefine, Author
Skovby, Flemming, Author
Rosenberg, Thomas, Author
Robinson, Peter N.2, Author           
Affiliations:
1Dept. of Human Molecular Genetics (Head: Hans-Hilger Ropers), Max Planck Institute for Molecular Genetics, Max Planck Society, ou_1433549              
2Research Group Development & Disease (Head: Stefan Mundlos), Max Planck Institute for Molecular Genetics, Max Planck Society, ou_1433557              

Content

show
hide
Free keywords: Marfan syndrome • MFS • fibrillin-1 • FBN1 • fibrillinopathy • temperature-gradient gel electrophoresis • TGGE • mutation screening • mutation detection
 Abstract: Mutations in the gene for fibrillin-1 (FBN1) cause Marfan syndrome (MFS), an autosomal dominant heritable disorder of connective tissue with prominent manifestations in the skeletal, ocular, and cardiovascular system. FBN1 mutations have also been identified in a series of related disorders of connective tissue collectively termed type-1 fibrillinopathies. We have developed temperature-gradient gel electrophoresis (TGGE) assays for all 65 FBN1 exons, screened 126 individuals with MFS, other type-1 fibrillinopathies, and other potentially related disorders of connective tissue for FBN1 mutations, and identified a total of 53 mutations, of which 33 are described here for the first time. Several mutations were identified in individuals with fibrillinopathies other than classic Marfan syndrome, including aneurysm of the ascending aorta with only minor skeletal anomalies, and several individuals with only skeletal and ocular involvement. The mutation detection rate in this study was 42% overall, but was only 12% in individuals not fulfilling the diagnostic criteria for MFS, suggesting that clinical overdiagnosis is one reason for the low detection rate observed for FBN1 mutation analysis. Hum Mutat 20:197-208, 2002. © 2002 Wiley-Liss, Inc.

Details

show
hide
Language(s): eng - English
 Dates: 2002-08-21
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: eDoc: 24751
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Human Mutation
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 20 (3) Sequence Number: - Start / End Page: 197 - 208 Identifier: -